Immunomodulatory effects of Lactiplantibacillus plantarum CCFM8661 + stachyose on cyclophosphamide-induced immunosuppression mice

Weiwei Ma, Hang Sun, Lian Lian, Lidong Guo, Yanyan Wang, Lili HuangFrontiers in Immunology 2025 · DOI

TL;DR

This study investigates how a combination of the probiotic Lactiplantibacillus plantarum CCFM8661 and the prebiotic stachyose can boost the immune system in mice treated with cyclophosphamide (CTX), a drug that suppresses immunity. The findings suggest this combination effectively mitigates CTX-induced immune damage by restoring immune organ health, improving gut barrier function, and rebalancing the gut microbiome.

What Problem Does This Paper Address?

The modern world's increasing stress levels and the ongoing threat of pandemics like COVID-19 highlight the critical need for robust immune systems. While traditional immunomodulators exist, they often come with significant side effects. This has spurred interest in alternative strategies, such as probiotics, to enhance immune function. Lactiplantibacillus plantarum and stachyose have individually shown promise in supporting immunity, but their combined effects and underlying mechanisms, particularly in the context of drug-induced immunosuppression, remain unclear. This paper aims to fill that gap by examining how this specific probiotic-prebiotic combination impacts the immune system of mice experimentally rendered immunocompromised.

Methods

The researchers employed a cyclophosphamide (CTX)-induced immunosuppression mouse model. BALB/c mice were divided into several groups: a normal control group, a model control group (receiving saline), a positive drug control group (levamisole hydrochloride), and groups receiving varying doses (low, medium, high) of Lactiplantibacillus plantarum CCFM8661 combined with stachyose. Treatments were administered orally for 28 days, with CTX administered on days 23 and 24 to induce immunosuppression.

Key analyses included:

  • Body Weight Monitoring: To assess overall health and the impact of treatments on weight loss.
  • Immune Organ Index: Measuring the weight of the thymus and spleen relative to body weight, as these organs are crucial for immune function and often atrophy under immunosuppression.
  • Delayed Type Hypersensitivity (DTH) Assay: To evaluate cellular immune function by measuring the inflammatory response to a specific antigen.
  • Serum Hemolysin Level: To assess humoral immune function by quantifying antibodies produced against sheep red blood cells (SRBC).
  • Histopathological Analysis of Ileum: Examining the small intestine's structure (villus height, crypt depth, goblet cell count) to assess gut barrier integrity.
  • Serum Cytokine Levels: Measuring key immune signaling molecules (IgA, IgG, TNF-α, IFN-γ, IL-2, IL-6, IL-12) using ELISA kits to understand the inflammatory and immune response.
  • Metagenomic Analysis: Analyzing fecal samples to characterize the gut microbial community composition and diversity using 16S rRNA sequencing.

Datasets

The study utilized a cyclophosphamide-induced immunosuppression mouse model. No specific public datasets were used for training or evaluation. The primary "dataset" generated was from the experimental mice themselves, with data collected from their physiological responses, immune markers, and gut microbiota.

Key Insights and Ideas

  • Synergistic Protection: The combination of L. plantarum CCFM8661 and stachyose appears to offer a synergistic protective effect against CTX-induced immunosuppression, outperforming individual components or simply mitigating damage.
  • Dose-Dependent Effects: For some parameters, particularly thymus index and certain cytokine levels, a dose-dependent response was observed, suggesting that higher doses of the combination may offer greater benefits.
  • Gut-Immune Axis Modulation: The study strongly implicates the gut microbiome as a key mediator of the observed immunomodulatory effects. The restoration of gut microbial diversity and the rebalancing of specific bacterial phyla (Bacteroidota and Bacillota) and genera (Muribaculaceae and Lachnospiraceae) are central to the observed immune improvements.
  • Comprehensive Immune Restoration: The combination not only boosted cellular and humoral immunity but also addressed structural damage to immune organs and the intestinal barrier, indicating a holistic approach to immune recovery.

Key Results

  • Weight Gain: The combination significantly mitigated weight loss induced by CTX, with dose-dependent increases observed in the medium and high-dose groups compared to the model control.
  • Immune Organ Indices: The thymus and spleen indices, which were reduced in the CTX-treated mice, were significantly restored by the probiotic-prebiotic combination, with the thymus showing a more pronounced response even at lower doses.
  • Cellular and Humoral Immunity: Both cellular immunity (DTH) and humoral immunity (serum hemolysin) were significantly improved by the combination, comparable to the positive control drug levamisole.
  • Intestinal Barrier: Histological analysis showed that the combination restored the integrity of the small intestinal villi, increased the villus height-to-crypt depth ratio, and improved goblet cell counts, all indicative of a healthier gut barrier.
  • Cytokine Levels: The combination helped normalize serum cytokine levels, which were dysregulated by CTX. Notably, IgA, IFN-γ, IL-2, IL-6, and IL-12 levels were significantly increased in the medium and high-dose groups.
  • Gut Microbiota: Alpha diversity (Simpson index) was enhanced by the combination. Beta diversity analysis showed that the treated groups' microbiota profiles shifted closer to that of the normal control group. Specifically, the abundance of beneficial Muribaculaceae increased, while the potentially detrimental Lachnospiraceae decreased, leading to a more balanced gut ecosystem.

Limitations and Future Work

The authors acknowledge several limitations:

  • Stachyose's Role: The study did not thoroughly investigate the specific effects of stachyose on the growth, viability, and metabolism of L. plantarum CCFM8661, which could influence their combined pharmacological effects. Future research should explore these interactions.
  • Animal Model vs. Human Relevance: Differences between mouse models and human physiology and gut microbiota mean that direct extrapolation of findings to humans requires further validation.
  • Mechanism Specificity: While correlations were found, the precise molecular mechanisms by which the combination interacts with the host immune system and gut microbiota require deeper investigation.

Future work should focus on elucidating these specific mechanisms, exploring the synergistic interactions between the probiotic and prebiotic, and conducting studies in human populations to confirm the therapeutic potential of this combination for immune health.

Summary updated

Abstract

The combination of <i>Lactiplantibacillus plantarum</i> CCFM8661 and stachyose has immune-enhancing effects, potentially achieved by regulating inflammation levels and maintaining intestinal homeostasis.
BibTeX
@inproceedings{ma2025immunomodulatory,
  author = {Weiwei Ma and Hang Sun and Lian Lian and Lidong Guo and Yanyan Wang and Lili Huang},
  title = {{Immunomodulatory effects of Lactiplantibacillus plantarum CCFM8661 + stachyose on cyclophosphamide-induced immunosuppression mice}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1513531},
}
Figure